Key mutations in the spike protein of SARS‐CoV‐2 affecting neutralization resistance and viral internalization
Journal of Medical Virology · 2023
DOI: 10.1002/jmv.28407 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Qiong Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Provincial Key Laboratory of Medical Virology, Institute of Pathogen Biology and Immunology, College of Biology, Hunan University, Changsha, Hu…. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
To control the ongoing COVID‐19 pandemic, a variety of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccines have been developed. However, the rapid mutations of SARS‐CoV‐2 spike (S) protein may reduce the protective efficacy of the existing vaccines which is mainly determined by the level of neutralizing antibodies targeting S. In this study, we screened prevalent S mutations and constructed 124 pseudotyped lentiviral particles carrying these mutants. We challenged these pseudoviruses with sera vaccinated by Sinovac CoronaVac and ZF2001 vaccines, two popular vaccines designed for the initial strain of SARS‐CoV‐2, and then systematically assessed the susceptivity of these SARS‐CoV‐2 variants to the immune sera of vaccines. As a result, 14 S mutants (H146Y, V320I + S477N, V382L, K444R, L455F + S477N, L452M + F486L, F486L, Y508H, P521R, A626S, S477N + S698L, A701V, S477N + T778I, E1144Q) were found to be significantly resistant to neutralization, indicating reduced protective efficacy of the vaccines against these SARS‐CoV‐2 variants. In addition, F486L and Y508H significantly enhanced the utilization of human angiotensin‐converting enzyme 2, suggesting a potentially elevated infectivity of these two mutants. In conclusion, our results show that some prevalent S mutations of SARS‐CoV‐2 reduced the protective efficacy of current vaccines and enhance the infectivity of the virus, indicating the necessity of vaccine renewal and providing direction for the development of new vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hunan Provincial Key Laboratory of Medical Virology, Institute of Pathogen Biology and Immunology, College of Biology, Hunan University, Changsha, Hunan, China.
- Hunan Prevention and Treatment Institute for Occupational Diseases, Changsha, Hunan, China.
- Department of Hospital Infection Control Center, Xiangya Hospital of Central South University, Changsha, China.
ORCID-Profile: Ye Qiu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, Q., Ye, S. B., Zhou, Z. J., Song, A. L., Zhu, X., Peng, J. M., Liang, R. M., Yang, C. H., Yu, X. W., Huang, X., Yu, J., Qiu, Y., & Ge, X. Y. (2023). Key mutations in the spike protein of SARS‐CoV‐2 affecting neutralization resistance and viral internalization. Journal of Medical Virology. https://doi.org/10.1002/jmv.28407
Vancouver
Wang Q, Ye SB, Zhou ZJ, Song AL, Zhu X, Peng JM, et al. Key mutations in the spike protein of SARS‐CoV‐2 affecting neutralization resistance and viral internalization. Journal of Medical Virology. 2023. doi:10.1002/jmv.28407
BibTeX
@article{Wang2023,
author = {Wang, Qiong and Ye, Sheng-Bao and Zhou, Zhi-Jian and Song, A-Ling and Zhu, Xi and Peng, Jia-Mei and Liang, Rui-Min and Yang, Chen-Hui and Yu, Xiao-Wei and Huang, Xun and Yu, Jie and Qiu, Ye and Ge, Xing-Yi},
title = {Key mutations in the spike protein of SARS‐CoV‐2 affecting neutralization resistance and viral internalization},
journal = {Journal of Medical Virology},
year = {2023},
doi = {10.1002/jmv.28407}
}
EUVIMED